Papapetropoulos Spyros bought NEUP
August 27, 2025 · Form 4 insider transaction
Papapetropoulos Spyros bought 34,559 shares of Neuphoria Therapeutics Inc. at $8.27 per share, a transaction worth $285.8K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
34,559
Price
$8.27
Total value
$285.8K
InsiderPapapetropoulos Spyros
Role—
SecurityEmployee Stock Option (Right-to- Buy)
Transaction codeA: Grant or award
Transaction dateAugust 27, 2025
Filing dateSeptember 2, 2025
Shares owned after74,088
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Subject to the Reporting Person's continuing service with the Company, the options shall vest on a monthly basis over a four-year period at the rate of 2.0833% of the shares of Common Stock on the last day of each month following August 1, 2025 until the options are fully vested.